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Objective.Blackthyroidisararepigmentedchange seen almostexclusively inpatients uponminocycline ingestion,andtheprocess
has previously been thought to be generally benign. There have been 61 reported cases of black thyroid. We are aware of 13 cases
previously reported in association with thyroid carcinoma. This paper reports six patients with black thyroid pigmentation in
association with thyroid carcinoma. Design. The medical records of six patients who were diagnosed with black thyroid syndrome,
allofwhomunderwentthyroidsurgery,werereviewed.Dataonage,gender,race,preoperativeﬁneneedleaspirationbiopsy(FNA),
thyroidfunctionlevels,andpathologyreportswerecollected.MainOutcome.Themeanagewas60years.Therewere5females,4of
whom were African American. All patients were clinically and biochemically euthyroid. Black pigmentation was not diagnosed in
preoperativeFNA,andonlyonepatienthadapreoperativediagnosisofpapillarythyroidcarcinoma.Theotherpatientsunderwent
surgery and were found to have black pigmentation of the thyroid associated with carcinoma. Conclusions. FNA does not diagnose
black thyroid, which is associated with thyroid carcinoma. Thyroid glands with black pigmentation deserve thorough pathologic
examination, including several sections of each specimen.
1.Introduction
Black thyroid is a rare condition. A recent review by Oertel
andcolleagueshasidentiﬁed61casesthathavebeenreported
to date [1]. Since the ﬁrst report of black thyroid in human
tissue [2], the etiology has been associated with minocycline
ingestion for year or more [2, 3]. Although minocycline has
been suggested as the cause of the pigmentation in many
cases [4–6], it has also been noted to occur subsequent
to infection [7], perhaps due to treatment with other
tetracycline derivatives [3].
Prescribed as an antibiotic for acne vulgaris, minocycline
has shown a rare yet seemingly speciﬁc relationship with
black thyroid [8]. The drug reacts with thyroid peroxidase
andformsablackpigmentwhichcouldbereadilyseeninhis-
tological preparations [6, 9–11]. It has been recommended
that (because of its antioxidant properties) coadministration
of ascorbic acid can protect against the discoloring eﬀects of
minocycline [12].
Oftenpresentingwithhypothyroidism,hyperthyroidism,
neck swelling, or no symptoms [8, 13–15], black thyroid is
distinguished by its melanin-like pigmentation and a lack of
autoimmune ﬂuorescence, iron deposits, or lipofuscin while
bleaching with potassium permanganate [7].
It has been recently recognized that black thyroid may be
involved in thyroid carcinoma, as the reported comorbidity
approximates 40% [16]. Thus, the recognition of black
thyroid necessitates serious consideration of coincidental
malignancy.
2.MaterialsandMethods
The medical records of six patients who were diagnosed
with black thyroid syndrome between January 2005 and
December 2007, all of whom underwent thyroid surgery,
w e r er e v i e w e d .D a t ao na g e ,g e n d e r ,r a c e ,p r e o p e r a t i v eﬁ n e
needle aspiration biopsy (FNA), thyroid function levels, and
pathology reports were collected (Table 1).2 International Journal of Endocrinology
Table 1: Patients’ demographics and pathology information.
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6
A g e6 85 2 5 7 5 95 86 6
Gender Female Male Male Female Female Female
Race White African
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Figure 1: Follicular variant of papillary thyroid carcinoma.
3. Results
T h em e a na g ew a s6 0y e a r s( ±5.9). There were 5 females,
and 4 of whom were African Americans. All patients were
clinically and biochemically euthyroid. Black pigmentation
was never diagnosed in preoperative FNA, and only one
patient had a preoperative diagnosis of papillary thyroid
carcinoma (Figure 1). Other patients underwent surgery for
compressive symptoms, suspicious nodules on ultrasound
(nodule size >1cm), or family history of thyroid cancer. All
patients were found to have black pigmentation (Figure 2)
of the thyroid. All patients were found to have thyroid carci-
noma on postoperative pathological examination (Table 1).
4. Discussion
Thyroid cancer occurs more commonly in women [17],
with papillary cancer being the most common type of
thyroid cancer. According to Mitchell and associates, the
northeastern and southern areas of the US have the highest
incidence [17]. The current series demonstrates that the high
incidence of black thyroid in this region of the country is
consistent.
T h em o s tr e l e v a n ts i d ee ﬀects of minocycline are dizzi-
ness, nausea, diarrhoea, hyperpigmentation of the skin, and
Figure 2: Fontana-Masson stain reduces ammonia-silver nitrate
and turns black (positive) in black thyroid.
a macroscopic black discoloration of the thyroid gland,
designated‘blackthyroidsyndrome’.Thisblackdiscoloration
of the thyroid is almost pathognomonic for the use of
minocycline [8]. Although many case reports describe an
association between minocycline-induced black thyroid and
malignancy [13, 16–19], a causal relationship has never been
proven. Hecht et al. described seven cases with black thyroid
with no malignancies [13].
Birkedalandcoworkershaverecommendedthatinciden-
taldiscoveryofblackthyroidshouldbedealtwithproactively
with surgical resection to stem the risk of papillary thyroid
carcinoma [16]. To further this contention, a literature
review in 2005 by Bruins and colleagues reported a 30%
(9/30) incidence of carcinoma in patients presenting with
black thyroid as opposed to a 0.003% (3/100,000) incidence
in the general population [8]. Although the diﬃculty of
diagnosis with ﬁne needle aspiration has been noted [1, 20],
past minocycline use signiﬁcantly increases the suspicion
of black thyroid, raising the question as to whether more
deﬁnitive measures are warranted to prevent carcinoma in
situ.International Journal of Endocrinology 3
5. Conclusion
Thyroid glands with black pigmentation deserve thorough
pathologic examination, which should include evaluation of
increased numbers of blocks sampled from each specimen.
However,theseﬁndingswarrantfurtherinvestigationtoclar-
ify the exact incidence of thyroid carcinoma in association
with black thyroid pigmentation.
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